(Q33821377)

29 July 2017

1 reference

title

Mastocytosis with skin manifestations: current status (English)

1 reference

29 July 2017

Katsamba AD

1

1 reference

29 July 2017

Karpouzis AJ

series ordinal

2

1 reference

29 July 2017

Koumantaki-Mathioudaki E

series ordinal

3

1 reference

29 July 2017

Jorizzo JL

series ordinal

4

1 reference

29 July 2017

language of work or name

1 reference

1 November 1999

1 reference

Journal of the European Academy of Dermatology and Venereology

29 July 2017

published in

1 reference

29 July 2017

volume

13

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

155-165

1 reference

New concepts about the mast cell

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

The mast cell and mast cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Mastocytosis: new understandings in cutaneous pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Adhesion molecules on the human mast cell line HMC-1 are upregulated during cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Two novel mast cell phenotypic markers, monoclonal antibodies Ki-MC1 and Ki-M1P, identify distinct mast cell subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Histamine: the quintessential mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

The treatment of mastocytosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.1999.TB00878.X

10.1111/J.1468-3083.1999.TB00878.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference